Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Polydipsia
ADR ID BADD_A03498
ADR Hierarchy
05      Endocrine disorders
05.03      Hypothalamus and pituitary gland disorders
05.03.03      Posterior pituitary disorders
05.03.03.002      Polydipsia
14      Metabolism and nutrition disorders
14.05      Electrolyte and fluid balance conditions
14.05.02      Fluid intake increased
14.05.02.001      Polydipsia
Description Excessive thirst manifested by excessive fluid intake. It is characteristic of many diseases such as DIABETES MELLITUS; DIABETES INSIPIDUS; and NEPHROGENIC DIABETES INSIPIDUS. The condition may be psychogenic in origin. [MeSH]
MedDRA Code 10036067
MeSH ID D059606
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Excessive drinking | Polydipsia | Polydipsia (nocturnal) | Polydypsia | Hydrodipsomania | Polydipsias
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01023Glimepiride0.000042%
BADD_D01083Hydrochlorothiazide0.000010%
BADD_D01133Ifosfamide--
BADD_D01149Indapamide0.000377%
BADD_D01243Lamotrigine0.000177%
BADD_D01275Levofloxacin0.000084%
BADD_D01281Levonorgestrel--
BADD_D01285Levothyroxine0.000017%
BADD_D01303Lithium carbonate0.001874%
BADD_D01304Lithium cation0.000998%
BADD_D01305Lithium hydroxide--
BADD_D01326Loxapine--
BADD_D01327Loxapine succinate--
BADD_D01378Memantine--
BADD_D01401Metformin0.000058%
BADD_D01431Methylphenidate0.000062%
BADD_D01470Minocycline0.000236%
BADD_D01476Mirtazapine0.000080%
BADD_D01535Naratriptan--
BADD_D01536Naratriptan hydrochloride--
BADD_D01599Olanzapine0.001263%
BADD_D01653Paclitaxel--
BADD_D01656Paliperidone0.010381%
BADD_D01679Paroxetine--
BADD_D01684Pasireotide0.000373%
BADD_D01831Prednisolone0.000035%
BADD_D01834Prednisone0.000013%
BADD_D01835Pregabalin0.000104%
BADD_D01888Quetiapine0.000055%
BADD_D01906Raltegravir potassium--
The 2th Page    First    Pre   2 3    Next   Last    Total 3 Pages
ADReCS-Target
ADR Term Drug Name Target